Congenital Adrenal Hyperplasia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
Condition: Congenital Adrenal Hyperplasia Interventions: Drug: Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Drug: Dual release hydrocortisone (plenadren) Sponsor: Federico II University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2018 Category: Research Source Type: clinical trials
Innovative Treatment in Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia Interventions: Drug: Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Drug: Dual release hydrocortisone (plenadren) Sponsor: Federico II University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2018 Category: Research Source Type: clinical trials
Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia Intervention: Drug: Subcutaneous hydrocortisone Sponsor: University of Minnesota - Clinical and Translational Science Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2018 Category: Research Source Type: clinical trials